Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA have higher lipid levels, increasing heart disease risk.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Young women with PCOS and no other heart risk factors have normal heart function.